Therapeutic Inertia in the Management of Moderate-to-Severe Plaque Psoriasis in Adolescents

Therapeutic Inertia in the Management of Moderate-to-Severe Plaque Psoriasis in Adolescents

Bibliographic Details
Main Authors:	Audrey Melin, Jean-François Sei, Florence Corgibet, Cristèle Nicolas, Rémi Maghia, Bruno Halioua, Alain Beauchet, Emmanuel Mahé
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2021-06-01
Series:	Acta Dermato-Venereologica
Subjects:	psoriasis adolescent therapeutic inertia treatment
Online Access:	https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3813

Similar Items

Therapeutic inertia in the management of patients with moderate to severe psoriasis: A systematic review of cross‐sectional studies
by: Jennifer Lavina Ngo, et al.
Published: (2025-03-01)

Therapeutic Inertia in the Management of Psoriasis: A Quantitative Survey Among Indian Dermatologists and Patients
by: Rajagopalan M, et al.
Published: (2022-08-01)

Therapeutic Inertia in Prescribing Biologics for Patients with Moderate-to-Severe Asthma: Workshop Summary
by: Sico IP, et al.
Published: (2021-04-01)

Use of clobetasol in lacquer for plaque psoriasis treatment
by: Suze Aparecida da Silva, et al.
Published: (2016-02-01)

Therapeutic inertia and contributing factors among ambulatory patients with hypertension
by: Yirga Legesse Niriayo, et al.
Published: (2024-09-01)

Real‐life self‐assessment of pruritus relief with a combination of calcipotriol/betamethasone dipropionate foam in patients with plaque psoriasis
by: Laurent Misery, et al.
Published: (2022-12-01)

Influence of Methotrexate on circulatory levels of T lymphocyte-related cytokines in patients with moderate to severe plaque psoriasis
by: Bei-bei SU, et al.
Published: (2020-10-01)

Virtual Inertia Coordinated Allocation Method Considering Inertia Demand and Wind Turbine Inertia Response Capability
by: Bo Xu, et al.
Published: (2021-08-01)

Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
by: Mahé E
Published: (2020-11-01)

Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
by: Martina Burlando, et al.
Published: (2021-05-01)

Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01)

Adherence, control of cardiometabolic factors and therapeutic inertia in patients with type 2 diabetes in the primary care setting
by: Domingo Orozco‐Beltrán, et al.
Published: (2022-03-01)

Serious generalized pustular psoriasis with evolution to plaque psoriasis: approach with spesolimab
by: Liz S. Gea, et al.
Published: (2024-10-01)

From pathogenesis to current treatment of the cutaneous psoriasis - a literature review
by: Wiktoria Jakubowska, et al.
Published: (2023-12-01)

Treatment challenges in the management of moderate-to-severe plaque psoriasis – role of secukinumab
by: Malakouti M, et al.
Published: (2016-10-01)

Inertia [filem]
Published: (1960)

Inertia [kasetvideo]
Published: (1960)

Frequency and outcomes of treatment dose escalation with biologics in moderate-to-severe psoriasis: a Swedish register study
by: Axel Svedbom, et al.
Published: (2024-12-01)

Clinical Utility of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis
by: Light JG, et al.
Published: (2021-01-01)

Entrepreneurial Behaviors: Are the People Restricted by Knowledge Inertia?
by: Mustafa Fedai Cavus, et al.
Published: (2014-03-01)

Unmet need for and impact of adopting immunobiological drugs for moderate to severe plaque psoriasis in a pediatric population
by: Ana Clara Maia Palhano, et al.
Published: (2024-06-01)

Phenotypic differences in clinical manifestations of generalized pustular psoriasis and severe plaque psoriasis in tropical Taiwan
by: Yin-Cheng Chao, et al.
Published: (2024-09-01)

Efficacy and safety of secukinumab for moderate to severe plaque psoriasis in children: A report of 10 cases
by: FU Tao, et al.
Published: (2024-10-01)

Ustekinumab in Real-Life Practice: Experience in 116 Patients with Moderate-To-Severe Psoriasis
by: Inês Raposo, et al.
Published: (2019-03-01)

Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis
by: Francesca Ambrogio, et al.
Published: (2022-08-01)

The Inertia of Mass and the Newtonian Force
by: Fabiana Botelho Kneubil
Published: (2020-12-01)

Topical therapies in psoriasis
by: R Torsekar, et al.
Published: (2017-01-01)

Therapeutic Inertia in the New Landscape of Multiple Sclerosis Care
by: Gustavo Saposnik, et al.
Published: (2018-03-01)

Choice of Systemic Drugs for the Management of Moderate-to-severe Psoriasis: A Cross-country Comparison Based on National Health Insurance Data
by: Emilie Sbidian, et al.
Published: (2021-06-01)

Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics
by: Ruggiero A, et al.
Published: (2023-11-01)

Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
by: Giovanna Malara, et al.
Published: (2021-05-01)

Comparative Role of Topical Betamethasone Valerate with Topical Calcipotriol in Mild and Moderate Plaque Type Psoriasis
by: sana imran, et al.
Published: (2014-08-01)

Comparative Role of Topical Betamethasone Valerate with Topical Calcipotriol in Mild and Moderate Plaque Type Psoriasis
by: sana imran, et al.
Published: (2014-08-01)

Comparative Role of Topical Betamethasone Valerate with Topical Calcipotriol in Mild and Moderate Plaque Type Psoriasis
by: Sana Imran, et al.
Published: (2014-08-01)

Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors
by: Nicole L. Bolick, et al.
Published: (2020-12-01)

Clinical observation of guselkumab in the treatment of 23 cases of moderate to severe plaque psoriasis
by: Liye XIA, et al.
Published: (2024-03-01)

The development of an instrument for measuring organisational inertia
by: C. Kinnear, et al.
Published: (1998-06-01)

Neutrophil/lymphocyte ratio as serum inflammatory biomarker in patients with moderate-to-severe plaque psoriasis
by: Maria E. Agapito-Valgas, et al.
Published: (2023-04-01)

Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
by: Di Lernia V, et al.
Published: (2016-01-01)

Use of Methotrexate in the Treatment of Moderate to Severe Plaque Psoriasis in France: A Practice Survey
by: Fougerousse AC, et al.
Published: (2021-04-01)